These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3504064)

  • 21. Aromatase.
    Osawa Y; Higashiyama T; Fronckowiak M; Yoshida N; Yarborough C
    J Steroid Biochem; 1987; 27(4-6):781-9. PubMed ID: 3320558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of the aromatase system associated with the mitochondrial fraction of human placenta.
    Canick JA; Ryan KJ
    Steroids; 1978 Nov; 32(4):499-509. PubMed ID: 725977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic identification of the aromatase enzyme system in human endometrium.
    Huang JR; Bellino FL; Osawa Y; Tseng L
    J Steroid Biochem; 1989 Dec; 33(6):1043-7. PubMed ID: 2533308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen synthetase in the horse. Comparison of equine placental and rat liver NADPH-cytrochrome c (P-450) reductase activities.
    Vibet A; Dintinger T; Maboundou JC; Gaillard JL; Divoux D; Silberzahn P
    FEBS Lett; 1990 Feb; 261(1):31-4. PubMed ID: 2106448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and immunological characterization of human placental mitochondrial cytochrome P-450.
    Pasanen M; Pelkonen O
    J Steroid Biochem; 1986 Mar; 24(3):669-75. PubMed ID: 3084875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of an activity-inhibiting monoclonal antibody against human placental aromatase cytochrome P450.
    Washida N; Kitawaki J; Higashiyama T; Matsui S; Osawa Y
    Steroids; 1996 Mar; 61(3):126-32. PubMed ID: 8852829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and properties of human placental NADPH-cytochrome P-450 reductase.
    Muto N; Tan L
    Biochem Cell Biol; 1986 Mar; 64(3):184-93. PubMed ID: 3087384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of equine testicular cytochrome P-450 aromatase: comparison with the human enzyme.
    Moslemi S; Vibet A; Papadopoulos V; Camoin L; Silberzahn P; Gaillard JL
    Comp Biochem Physiol B Biochem Mol Biol; 1997 Sep; 118(1):217-27. PubMed ID: 9418012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solubilization of estrogen synthetase from human term placental microsomes using detergents.
    Bellino FL; Osawa Y
    J Steroid Biochem; 1978 Mar; 9(3):219-28. PubMed ID: 418271
    [No Abstract]   [Full Text] [Related]  

  • 31. Functional ovarian and placental isoforms of porcine aromatase.
    Corbin CJ; Khalil MW; Conley AJ
    Mol Cell Endocrinol; 1995 Aug; 113(1):29-37. PubMed ID: 8674811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of aromatase cytochrome P-450 by 10-oxirane and 10-thiirane substituted androgens. Implications for the structure of the active site.
    Kellis JT; Childers WE; Robinson CH; Vickery LE
    J Biol Chem; 1987 Mar; 262(9):4421-6. PubMed ID: 3558412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of a cytochrome P-450 that catalyzes the 25-hydroxylation of vitamin D3 from rat liver microsomes.
    Hayashi S; Noshiro M; Okuda K
    J Biochem; 1986 Jun; 99(6):1753-63. PubMed ID: 3745145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P-450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain. Evidence for constitutive presence in rat and human brain.
    Anandatheerthavarada HK; Boyd MR; Ravindranath V
    Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):483-8. PubMed ID: 1463452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple forms of aromatase and response of breast cancer aromatase to antiplacental aromatase II antibodies.
    Osawa Y; Tochigi B; Higashiyama T; Yarborough C; Nakamura T; Yamamoto T
    Cancer Res; 1982 Aug; 42(8 Suppl):3299s-3306s. PubMed ID: 6177401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The active site of aromatase cytochrome P-450. Differential effects of cyanide provide evidence for proximity of heme-iron and carbon-19 in the enzyme-substrate complex.
    Kellis JT; Vickery LE
    J Biol Chem; 1987 Jun; 262(18):8840-4. PubMed ID: 3597396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
    Swinney DC; Watson DM; So OY
    Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereochemistry of estrogen biosynthesis by a reconstituted aromatase cytochrome P-450 preparation from human placenta.
    Muto N; Tan L
    Biochem Biophys Res Commun; 1986 Apr; 136(2):454-62. PubMed ID: 3707583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different in vitro metabolism of 7 alpha-methyl-19-nortestosterone by human and equine aromatases.
    Moslemi S; Dintinger T; Dehennin L; Silberzahn P; Gaillard JL
    Eur J Biochem; 1993 Jun; 214(2):569-76. PubMed ID: 8513806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen synthetase. Demonstration that the high molecular weight form of NADPH-cytochrome C reductase from human placental microsomes is required for androgen aromatization.
    Bellino FL
    J Steroid Biochem; 1982 Sep; 17(3):261-70. PubMed ID: 6813599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.